Literature DB >> 18190327

HIV seroprevalence among women opting out of prenatal HIV screening in Alberta, Canada: 2002-2004.

Sabrina S Plitt1, Ameeta E Singh, Bonita E Lee, Jutta K Preiksaitis.   

Abstract

Alberta, Canada, uses an "opt-out" strategy for prenatal HIV testing. We examined demographic characteristics of and HIV seroprevalence among women opting out. The proportion of total specimens that were from women who opted out decreased from 4.3% in 2002 to 3.6% in 2004 (P<.001), and HIV seroprevalence among these specimens was 0.07%, which was 3.3 times higher than the HIV seroprevalence among specimens from women who opted in. Women opting out may have a higher HIV infection risk.

Entities:  

Mesh：

Year:  2007        PMID： 18190327     DOI： 10.1086/523730

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

2.  High HIV-TB co-infection rates in marginalized populations: evidence from Alberta in support of screening TB patients for HIV.

Authors:  Richard Long; Jody Boffa
Journal:  Can J Public Health       Date:  2010 May-Jun

3.  Examination of a Canadian provincial prenatal HIV screening program: 2010 to 2014.

Authors:  Sabrina S Plitt; Trenton R Smith; Warren Berry; Mariam Osman; Ambikaipakan Senthilselvan; Carmen L Charlton
Journal:  Can J Public Health       Date:  2020-02-03

4.  Prevalence of HIV among women entering labor who accepted or declined voluntary counseling and testing.

Authors:  Gerhard B Theron; Mae P Cababasay; Russell B Van Dyke; David E Shapiro; Jeanne Louw; D Heather Watts; Marc Bulterys; Linda M Styer; Robert Maupin
Journal:  Int J Gynaecol Obstet       Date:  2012-11-09       Impact factor: 3.561

5.  Risk, reasons for refusal, and impact of counseling on consent among ED patients declining HIV screening.

Authors:  Nitin D Ubhayakar; Christopher J Lindsell; Dana L Raab; Andrew H Ruffner; Alexander T Trott; Carl J Fichtenbaum; Michael S Lyons
Journal:  Am J Emerg Med       Date:  2010-03-25       Impact factor: 2.469

6.  Prenatal screening and perinatal HIV transmission in Northern Alberta, 1999-2006.

Authors:  Christine A Hughes; Dalyce Zuk; Michelle Foisy; Joan Robinson; Ameeta E Singh; Stan Houston
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

7.  Factors associated with declining a rapid human immunodeficiency virus test in labor and delivery.

Authors:  Kathrine R Tan; Margaret A Lampe; Susan P Danner; Patricia Kissinger; Mayris P Webber; Mardge H Cohen; Mary Jo O'Sullivan; Steven Nesheim; Denise J Jamieson
Journal:  Matern Child Health J       Date:  2011-01

8.  The changing demographics of women living with HIV/AIDS in southern Alberta from 1982 to 2006.

Authors:  Liana Hwang; Jesse Raffa; Michael John Gill
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

9.  High HIV prevalence among low-income, Black women in New York City with self-reported HIV negative and unknown status.

Authors:  Kathleen H Reilly; Alan Neaigus; Samuel M Jenness; Holly Hagan; Travis Wendel; Camila Gelpí-Acosta
Journal:  J Womens Health (Larchmt)       Date:  2013-08-09       Impact factor: 2.681

10.  Randomized comparison of universal and targeted HIV screening in the emergency department.

Authors:  Michael S Lyons; Christopher J Lindsell; Andrew H Ruffner; D Beth Wayne; Kimberly W Hart; Matthew I Sperling; Alexander T Trott; Carl J Fichtenbaum
Journal:  J Acquir Immune Defic Syndr       Date:  2013-11-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.